Development of up-converting phosphor technology-based lateral-flow assay for rapidly quantitative detection of hepatitis B surface antibody

Diagnostic Microbiology and Infectious Disease

Volumn 63, Issue 2, 2009, Pages 165-172

  Li, Luping ^a,b   Zhou, Lei ^c   Yu, Yang ^b   Zhu, Ziwen ^c   Lin, Changqing ^d   Lu, Changlong ^a   Yang, Ruifu ^c  

^a CHINA MEDICAL UNIVERSITY   (China)

^b The Sixth People's Hospital of Shenyang City   (China)

^c BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^d Beijing Hotgen Biotech Co Ltd   (China)

Author keywords

Biosensor; Clinical quantitative detection; Hepatitis B surface antibody; Lateral flow strip; Up converting phosphor technology

Indexed keywords

ERBIUM; HEPATITIS B SURFACE ANTIBODY; SODIUM YTTRIUM FLUORIDE; UNCLASSIFIED DRUG; YTTERBIUM; YTTRIUM;

ANTIBODY DETECTION; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INTERMETHOD COMPARISON; PRIORITY JOURNAL; QUANTITATIVE ASSAY; SENSITIVITY AND SPECIFICITY;

BIOSENSING TECHNIQUES; EQUIPMENT DESIGN; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HUMANS; IMMUNOASSAY; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 58249123479     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2008.10.020     Document Type: Article

References (40)

1. Abrams W.R., Barber C.A., McCann K., Tong G., Chen Z., Mauk M.G., Wang J., Volkov A., Bourdelle P., Corstjens P.L., Zuiderwijk M., Kardos K., Li S., Tanke H.J., Sam Niedbala R., Malamud D., and Bau H. Development of a microfluidic device for detection of pathogens in oral samples using upconverting phosphor technology (UPT). Ann. N. Y. Acad. Sci. 1098 (2007) 375-388
2. Bienzle U., Gunther M., Neuhaus R., Vandepapeliere P., Vollmar J., Lun A., and Neuhaus P. Immunization with an adjuvant hepatitis B vaccine after liver transplantation for hepatitis B-related disease. Hepatology 38 (2003) 811-819
3. Bock H.L., Kruppenbacher J., Sanger R., Hobel W., Clemens R., and Jilg W. Immunogenicity of a recombinant hepatitis B vaccine in adults. Arch. Intern. Med. 156 (1996) 2226-2231
4. Corstjens P.L., van Lieshout L., Zuiderwijk M., Kornelis D., Tanke H.J., Deelder A.M., and van Dam G.J. Up-converting phosphor technology-based lateral flow assay for detection of Schistosoma circulating anodic antigen in serum. J. Clin. Microbiol. 46 (2008) 171-176
5. Corstjens P.L., Zuiderwijk M., Brink A., Li S., Feindt H., Niedbala R.S., and Tanke H. Use of up-converting phosphor reporters in lateral-flow assays to detect specific nucleic acid sequences: a rapid, sensitive DNA test to identify human papillomavirus type 16 infection. Clin. Chem. 47 (2001) 1885-1893
6. Corstjens P.L., Zuiderwijk M., Nilsson M., Feindt H., Sam Niedbala R., and Tanke H.J. Lateral-flow and up-converting phosphor reporters to detect single-stranded nucleic acids in a sandwich-hybridization assay. Anal. Biochem. 312 (2003) 191-200
7. Corstjens P.L., Zuiderwijk M., Tanke H.J., van der Ploeg-van Schip J.J., Ottenhoff T.H., and Geluk A. A user-friendly, highly sensitive assay to detect the IFN-gamma secretion by T cells. Clin. Biochem. 41 (2008) 440-444
8. Daryani N.E., Nassiri-Toosi M., Rashidi A., and Khodarahmi I. Immunogenicity of recombinant hepatitis B virus vaccine in patients with and without chronic hepatitis C virus infection: a case-control study. World J. Gastroenterol. 13 (2007) 294-298
9. Estevez Z.C., Betancourt A.A., Muzio Gonzalez V., Baile N.F., Silva C.V., Bernal F.H., Arias E.P., Delhanty Fernandez A., Olazabal N.M., del Rio Martin A., Batista L.L., Veliz Rios G., Hernandez H.H., Hernandez A.B., Lugo E.P., de la Torre Cruz J., Batista Marchec B.L., Falcon L.A., Brito J.T., Leon D.O., and Saura P.L. Immunogenicity and safety assessment of the Cuban recombinant hepatitis B vaccine in healthy adults. Biologicals 35 (2007) 115-122
10. Gorska P. Humoral immunological response in laboratory animals after vaccination with recombinant vaccines against viral hepatitis B of different generations. Przegl. Epidemiol. 61 (2007) 393-400
11. Hammitt L.L., Hennessy T.W., Fiore A.E., Zanis C., Hummel K.B., Dunaway E., Bulkow L., and McMahon B.J. Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years. Vaccine 25 (2007) 6958-6964
12. Hampl J., Hall M., Mufti N.A., Yao Y.M., MacQueen D.B., Wright W.H., and Cooper D.E. Upconverting phosphor reporters in immunochromatographic assays. Anal. Biochem. 288 (2001) 176-187
13. Hsu H.M., Lee S.C., Wang M.C., Lin S.F., and Chen D.S. Efficacy of a mass hepatitis B immunization program after switching to recombinant hepatitis B vaccine: a population-based study in Taiwan. Vaccine 19 (2001) 2825-2829
14. Ismail N., Fish G.E., and Smith M.B. Laboratory evaluation of a fully automated chemiluminescence immunoassay for rapid detection of HBsAg, antibodies to HBsAg, and antibodies to hepatitis C virus. J. Clin. Microbiol. 42 (2004) 610-617
15. Isolani A.P., Sversuti C.S., Sell A.M., and Moliterno R.A. Protection against hepatitis B by the Butang recombinant vaccine in newborn children in South Brazil. Mem. Inst. Oswaldo Cruz 101 (2006) 551-553
16. Karelin V.P., Babaeva E.E., Gubenko E.F., Kaulen D.K., and Zhdanov V.M. A vaccine prepared from the 22 nm particles of surface hepatitis B antigen (HBsAg). J. Med. Virol. 5 (1980) 331-341
17. Louther J., Feldman J., Rivera P., Villa N., DeHovitz J., and Sepkowitz K.A. Hepatitis B vaccination program at a New York City hospital: seroprevalence, seroconversion, and declination. Am. J. Infect. Control 26 (1998) 423-427
18. Mokkapati V.K., Sam Niedbala R., Kardos K., Perez R.J., Guo M., Tanke H.J., and Corstjens P.L. Evaluation of UPlink-RSV: prototype rapid antigen test for detection of respiratory syncytial virus infection. Ann. N. Y. Acad. Sci. 1098 (2007) 476-485
19. Moynihan J.S., D'Mello F.I., and Howard C.R. 48-mer synthetic peptide analogue of the hepatitis B virus "a" determinant induces an anti-HBs antibody response after a single injection. J. Med. Virol. 62 (2000) 159-166
20. Niedbala R.S., Feindt H., Kardos K., Vail T., Burton J., Bielska B., Li S., Milunic D., Bourdelle P., and Vallejo R. Detection of analytes by immunoassay using up-converting phosphor technology. Anal. Biochem. 293 (2001) 22-30
21. Niedbala R.S., Vail T.L., Feindt H., Li S., and Burton J.L. Multiphoton up-converting phosphors for use in rapid immunoassays. In: Cohn G.E. (Ed). In-vitro diagnostic instrumentation. Proceedings of Spie 3913 (2000) 193-203
22. Ogata N. Measurements in international units of antibody to hepatitis B surface antigen (anti-HBs) after immunization with a yeast-derived, subtype adr hepatitis B vaccine are considerably different between chemiluminescent immunoassay (CLIA) and chemiluminescent enzyme immunoassay (CLEIA). Rinsho Byori 54 (2006) 340-343
23. Ozaki T., Mochizuki H., Ichikawa Y., Fukuzawa Y., Yoshida S., and Morimoto M. Persistence of hepatitis B surface antibody levels after vaccination with a recombinant hepatitis B vaccine: a 3-year follow-up study. J. Oral Sci. 42 (2000) 147-150
24. Pasricha N., Datta U., Chawla Y., Singh S., Arora S.K., Sud A., Minz R.W., Saikia B., Singh H., James I., and Sehgal S. Immune responses in patients with HIV infection after vaccination with recombinant hepatitis B virus vaccine. BMC Infect. Dis. 6 (2006) 65
25. Platkov E., Shlyakhov E., Glick Y., Khalemsky S., and Fischbein A. Immunologic evaluation of hepatitis B vaccine application in hospital staff. Int. J. Occup. Med. Environ. Health 16 (2003) 249-253
26. Rajapurkar M.M., Gang S., Dabhi M., and Kulkarni P.S. Comparative immunogenicity of 2 recombinant hepatitis B vaccines (GeneVac-B and Engerix-B) in adult patients with chronic renal failure. J. Nephrol. 20 (2007) 596-601
27. Roome A.J., Walsh S.J., Cartter M.L., and Hadler J.L. Hepatitis B vaccine responsiveness in Connecticut public safety personnel. JAMA 270 (1993) 2931-2934
28. Saberifiroozi M., Gholamzadeh S., and Serati A.R. The long-term immunity among health care workers vaccinated against hepatitis B virus in a large referral hospital in southern Iran. Arch. Iran Med. 9 (2006) 204-207
29. Shetty K., Hussain M., Nei L., Reddy K.R., and Lok A.S. Prevalence and significance of occult hepatitis B in a liver transplant population with chronic hepatitis C. Liver Transpl. 14 (2008) 534-540
30. Tam J.P., and Lu Y.A. Vaccine engineering: enhancement of immunogenicity of synthetic peptide vaccines related to hepatitis in chemically defined models consisting of T- and B-cell epitopes. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 9084-9088
31. Velu V., Nandakumar S., Shanmugam S., Shankar E.M., Thangavel S., Kulkarni P.S., and Thyagarajan S.P. Comparative efficacy of two dosages of recombinant hepatitis B vaccine in healthy adolescents in India. Pediatr. Infect. Dis. J. 26 (2007) 1038-1041
32. Wang J., Chen Z., Corstjens P.L., Mauk M.G., and Bau H.H. A disposable microfluidic cassette for DNA amplification and detection. Lab. Chip. 6 (2006) 46-53
33. Watkins S.L., Alexander S.R., Brewer E.D., Hesley T.M., West D.J., Chan I.S., Mendelman P., Bailey S.M., Burns J.L., and Hogg R.J. Response to recombinant hepatitis B vaccine in children and adolescents with chronic renal failure. Am. J. Kidney Dis. 40 (2002) 365-372
34. West D.J., and Calandra G.B. Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination. Vaccine 14 (1996) 1019-1027
35. Xu R., Gan X., Fang Y., Zheng S., and Dong Q. A simple, rapid, and sensitive integrated protein microarray for simultaneous detection of multiple antigens and antibodies of five human hepatitis viruses (HBV, HCV, HDV, HEV, and HGV). Anal. Biochem. 362 (2007) 69-75
36. Yan Z., Zhou L., Zhao Y., Wang J., Huang L., Hu K., Liu H., Wang H., Guo Z., Song Y., Huang H., and Yang R. Rapid quantitative detection of Yersinia pestis by lateral-flow immunoassay and up-converting phosphor technology-based biosensor. Sens. Actuators B Chem. 119 (2006) 656-663
37. Yen Y.H., Chen C.H., Wang J.H., Lee C.M., Changchien C.S., and Lu S.N. Study of hepatitis B (HB) vaccine non-responsiveness among health care workers from an endemic area (Taiwan). Liver Int. 25 (2005) 1162-1168
38. Zeeshan M., Jabeen K., Ali A.N., Ali A.W., Farooqui S.Z., Mehraj V., and Zafar A. Evaluation of immune response to hepatitis B vaccine in health care workers at a tertiary care hospital in Pakistan: an observational prospective study. BMC Infect. Dis. 7 (2007) 120
39. Zuckerman J.N. Review: hepatitis B immune globulin for prevention of hepatitis B infection. J. Med. Virol. 79 (2007) 919-921
40. Zuiderwijk M., Tanke H.J., Sam Niedbala R., and Corstjens P.L. An amplification-free hybridization-based DNA assay to detect Streptococcus pneumoniae utilizing the up-converting phosphor technology. Clin. Biochem. 36 (2003) 401-403